Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 4389 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Santarus launches Zegerid 40mg in the US

Santarus has initiated shipments of Zegerid (omeprazole) powder for oral suspension 40mg to pharmaceutical wholesalers that distribute to retail pharmacies, hospitals and other institutional customers. This product is

Nautilus reaches first Serono deal milestone

The development of the next-generation human growth hormone (hGH) may allow less frequent injections of this important therapeutic protein, which is currently administered daily. Using its protein evolution

NicOx allergy spray brings rapid relief

These new rapid relief results follow the announcement in June 2004, that NCX 1510 had reached the primary efficacy endpoint of a phase IIa study in patients suffering

Advitech to test bowel inflammation agent

The in vivo study will use a recognized animal model of chronic inflammatory diseases, the HLA-B27T transgenic rat model. The study should be completed by the end of

Bavarian Nordic extends R&D investments

“We are actively expanding our international marketing function and intend to invest in a vaccine filling line to ensure security of supply for these customers,” commented Peter Wulff,